20356 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR PROMOTING NEUROGENESIS AND INHIBITING CELL DEATH
#302Antiviral compounds
#303COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS
#304Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
#305Indole derivative used as CRTH2 inhibitor
#306Tricyclic quinone derivative
#307TREATMENT OF FIBROTIC DISORDERS WITH JUN N-TERMINAL KINASE INHIBITORS
#308Combination containing sGC activators and mineralocorticoid receptor antagonists
#309Degradation of tripartite motif-containing protein 24 (TRIM24) by conjugation of TRIM24 inhibitors with E3 ligase ligand and methods of use
#310N-(substituted-phenyl)-sulfonamide derivatives as kinase inhibitors
#311Thieno[2,3-b]pyridine derivative, quinoline derivative, and use thereof
#312USE OF SMALL MOLECULES FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE TOXICITY
#313Pharmaceutical composition containing Ginkgolide B and ADP receptor antagonist, preparation method thereof and use thereof
#314METHOD OF TREATING CARDIOVASCULAR EVENTS USING COLCHICINE CONCURRENTLY WITH AN ANTIPLATELET AGENT
#315Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer
#316Compounds for treatment of hypoproliferative disorders
#317Methods for inhibiting muscle atrophy
#318Compounds and compositions for the inhibition of NAMPT
#319Inhibitors of hepatitis B virus targeting capsid assembly
#320Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
#321Ring-fused thiazolino 2-pyridones, methods for preparation thereof and their use in the treatment and/or prevention of tuberculosis
#322Dry powder formulations for inhalation
#323METHODS OF TREATING AUTOPHAGY-ASSOCIATED DISORDERS AND RELATED PHARMACEUTICAL COMPOSITIONS, DIAGNOSTICS, SCREENING TECHNIQUES AND KITS
#324Imidazolylamide derivative
#325OPTICALLY ACTIVE 2-HYDROXY TETRAHYDROTHIENOPYRIDINE DERIVATIVES, PREPARATION METHOD AND USE IN MANUFACTURE OF MEDICAMENT THEREOF
#326Peptide-based methods for treating neurological injury
#327TREATING AND PREVENTING DISEASE WITH TMA AND TMAO LOWERING AGENTS
#328CONTROLLED DOSING OF CLOPIDOGREL WITH GASTRIC ACID INHIBITION THERAPIES
#329ANTIVIRAL COMPOUNDS AND METHODS OF USE THEREOF
#330Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
#331SUBSTANCE THAT INHIBITS P2Y12 RECEPTOR, FOR USE IN THE PREVENTIVE TREATMENT OF SYSTEMIC SCLEROSIS IN PATIENTS WITH RAYNAUD'S PHENOMENON AND A DYSIMMUNITY
#332Valproic acid for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formation
#333Treatment of autophagy-based disorders and related pharmaceutical compositions, diagnostic and screening assays and kits
#334Fused imidazole derivatives as TGF-beta inhibitors
#335Heterocyclic compounds
#336COMPOSITIONS AND METHODS FOR TREATMENT, AMELIORATION, AND PREVENTION OF DIABETES-RELATED SKIN ULCERS
#337Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
#338VALPROIC ACID FOR TREATMENT OF MYOCARDIAL ISCHEMIA
#339METHODS AND COMPOSITIONS USING AMPK ACTIVATORS FOR PHARMACOLOGICAL PREVENTION OF CHRONIC PAIN
#340Methods of treating muscular dystrophy
#341ANDROGEN RECEPTOR LIGANDS
#342PARTICLES, COMPOSITIONS AND METHODS FOR OPHTHALMIC AND/OR OTHER APPLICATIONS
#343Methods of treating muscular dystrophy
#344Compound having effect of inhibiting platelet aggregation and salt thereof, and composition for preventing or treating thrombotic diseases, containing same
#345LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS
#346Drone based security system
#347cGAS antagonist compounds
#348Formulations and compositions for rejuvenation of the body
#349Heteroaromatic Compounds and their Use as Dopamine D1 Ligands
#350Bicyclic heterocyclic amide derivative
#351Thienopyridine derivative for the treatment of hepatitis C infections
#352Treatment for myopathy
#353Valproic acid for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formation
#354Inhibitors of PTP4A3 for the treatment of cancer
#355Histone deacetylase inhibitors
#356Assessment of cardiac health and thrombotic risk in a patient
#357Inhibitors of short-chain dehydrogenase activity for modulating hematopoietic stem cells and hematopoiesis
#358STABLE PHARMACEUTICAL COMPOSITION OF CLOPIDOGREL FREE BASE FOR ORAL AND PARENTERAL DELIVERY
#359COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY
#360Drug for preventing and/or treating dementia
#361Treating or preventing nephrogenic diabetes insipidus
#362ANTIVIRAL COMPOUNDS
#363Compounds, compositions and methods useful for cholesterol mobilization
#364Inhibitors of short-chain dehydrogenase activity for treating fibrosis
#365Process of forming crystals for use in a personal care composition
#366Inhibitors of the kynurenine pathway
#367THERAPEUTIC AND PROPHYLACTIC METHODS, USES AND COMPOSITIONS COMPRISING ANEXIN A5
#368Preparation and use of 7a-heterocycle substituted-6,6-difluoro bicyclic himbacine derivatives as PAR-1 receptor antagonists
#369Compounds and methods for treating HIV infection
#370Unit aerosol doses for anticoagulation
#371HETEROARYL ESTROGEN RECEPTOR MODULATORS AND USES THEREOF
#372AGENT FOR PREVENTING AND/OR TREATING AMYOTROPHIC LATERAL SCLEROSIS
#373ANTIPLATELET AGENT AND USES THEREOF
#374Compounds and compositions for the inhibition of NAMPT
#375Adoptive immunotherapy for treating cancer
#376Dry powder formulations for inhalation
#377COMBINATION THERAPIES
#378Method of Ameliorating Clotting Pathologies and Related Materials and Methods
#379SUBSTITUTED 6-AZA-ISOINDOLIN-1-ONE DERIVATIVES
#380Method of treating cardiovascular events using colchicine concurrently with an antiplatelet agent
#381Pharmaceutical composition containing Ginkgolide B and ADP receptor antagonist, preparation method thereof and use thereof
#382INHALATION-TYPE PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF GOUT AND PREPARATION METHOD THEREOF
#383Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
#384Prevention of atherosclerotic events with direct factor Xa inhibitors
#385PHARMACEUTICAL COMPOSITION FOR SUPPRESSION OF THROMBOEMBOLISM AFTER STENT PLACEMENT
#386Compounds for the treatment of paramyxovirus viral infections
#387INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL
#388Therapeutic agent for motor disorders
#389Treating and preventing disease with TMA and TMAO lowering agents
#390Pharmaceutical Compositions For Poorly Water-Soluble Compounds
#391Treatment of pancreatic and related cancers with 5-acyl-6,7-dihydrothieno[3,2-c]pyridines
#392COMPOUNDS FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASE
#393Inhibitors of short-chain dehydrogenase activity for modulating hematopoietic stem cells and hematopoiesis
#394Inhibitors of bacterial DNA gyrase with efficacy against gram-negative bacteria
#395Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
#396Compositions and methods of modulating short-chain dehydrogenase activity
#397METHOD FOR DETECTING OR TREATING TRIPLE NEGATIVE BREAST CANCER
#398Heteroaromatic Compounds and their Use as Dopamine D1 Ligands
#399Compositions and methods of modulating 15-PGDH activity
#400Clopidogrel Hydrogen Sulfate Solid Preparation and Its Preparation Method
#401Use of small molecules for the treatment of clostridium difficile toxicity
#402THIENOPYRIDINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS
#403Optically active 2-hydroxy tetrahydrothienopyridine derivatives, preparation method and use in manufacture of medicament thereof
#404Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
#405Compounds that enhance Atoh1 expression
#406SPATIOTEMPORALLY MULTICONTROLLABLE INTELIGENT DRUG-ELUTING STENT
#407Antiviral axin stabilizer
#408Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
#409Maintenance of platelet inhibition during antiplatelet therapy
#410Compounds for treating viral infections
#411Thienopyridine derivative for the treatment of hepatitis C infections
#412Stable pharmaceutical composition of clopidogrel free base for oral and parenteral delivery
#413Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
#414Treating or preventing nephrogenic diabetes insipidus
#415Compounds, compositions and methods useful for cholesterol mobilization
#416INHIBITORS OF HIV REPLICATION
#417Treatment of Levodopa-induced Dyskinesias
#418Methods of treating, reducing the incidence of, and/or preventing ischemic events
#419Compounds and methods for preventing, treating and/or protecting against sensory hair cell death
#420Compounds inhibiting eukaryotic elongation factor 2 kinase activity
#421Castration-resistant prostate cancer
#422Combination Therapy Of Substituted Oxazolidinones
#423Use of indolyl and indolinyl hydroxamates for treating neurodegenerative disorders or cognitive decicits
#424Thieno[3,2-C]pyridin-4(5H)-ones as BET inhibitors
#425Methods and compositions for treating nephrogenic diabetes insipidus
#426Heterocyclic compounds
#427Methods for inhibiting muscle atrophy
#428Biomarkers for diagnosis of transient ischemic attacks
#429Compounds and methods for the treatment of vascular disease
#430Therapeutic pyrazolyl thienopyridines
#431Preparation and use of 3-pyridyl substituted-6,6-difluoro bicyclic himbacine derivatives as par-1 receptor antagonists
#432Preparation and use of 7a-amide substituted- 6,6-difluoro bicyclic himbacine derivatives as PAR-1 receptor antagonists
#433THIENOPYRIDINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS
#434COMPOUNDS FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASE
#435Treatment of pancreatic and related cancers with 5-acyl-6,7-Dihydrothieno[3,2-C]pyridines
#436Antiviral compounds and methods of use thereof
#437Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopidogrel therapy
#438Histone deacetylase inhibitors
#439METHODS AND COMPOSITIONS FOR INHIBITING HUMAN COPPER TRAFFICKING PROTEINS ATOX1 AND CCS
#440Methods and compositions for preventing and treating electrophile-mediated toxicities
#441Assessment of cardiac health and thrombotic risk in a patient
#442Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
#443CC-1065 analogs and their conjugates
#444Inhibitors of the kynurenine pathway
#445Dry powder formulations for inhalation
#446Combinations of Oral Medicaments Bonded by a Wrapping
#447Compounds, compositions and methods useful for cholesterol mobilization
#448Heteroaromatic compounds and their use as dopamine D1 ligands
#449COMPOSITION FOR THE TREATMENT OR PROPHYLAXIS OF THROMBOSIS OR EMBOLISM
#4502-aryl selenazole compound and pharmaceutical composition thereof
#451Methods of treating muscular dystrophy
#452Substituted 6-aza-isoindolin-1-one derivatives
#453Treatment or prevention of cardiovascular events via the administration of a colchicine derivative
#454Inhalation-type pharmaceutical composition for the treatment of arthritis and preparation method thereof
#455Inhalation-type pharmaceutical composition for the treatment of heart disease and preparation method thereof
#456Inhalation-type pharmaceutical composition for the treatment of Alzheimer's disease and preparation method thereof
#457Inhalation-type pharmaceutical composition for the treatment of Parkinson's disease and preparation method thereof
#458Peptide directed protein knockdown
#459TREATMENT OF AUTOPHAGY-BASED DISORDERS AND RELATED PHARMACEUTICAL COMPOSITIONS, DIAGNOSTIC AND SCREENING ASSAYS AND KITS
#460SOFT ELASTIC CAPSULES CONTAINING TABLETS AND LIQUID OR SEMISOLID FILLS AND METHODS FOR THEIR MANUFACTURE
#461Compounds and methods for preventing, treating and/or protecting against sensory hair cell death
#462Sugar derivatives comprising sulfur-containing moieties and methods of making same and methods of using the same for the treatment of MPS IIIC
#463Therapeutic agent for motor disorders
#464LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS
#465Compounds for the treatment of associated disease
#466METHOD OF TREATING CARDIOVASCULAR EVENTS USING COLCHICINE CONCURRENTLY WITH AN ANTITHROMBOTIC DRUG
#467Method of treating cardiovascular events using colchicine concurrently with an antiplatelet agent
#468Pharmaceutical Compositions For Poorly Water-Soluble Compounds
#469PNEUMATIC WRAP COMPRESSION TREATMENTS FOR VENOUS CONDITIONS
#470Therapeutic pyrazolyl thienopyridines
#4713-O-heteroaryl-ingenol
#472Anti-thrombotic compositions and methods for assaying platelet reactivity and treatment selection
#473Preparation method of the solid formulation of Clopidogrel bisulfate
#4742,5-dialkyl-4-H/halo/ether-phenol compounds
#475COMPOSITIONS CONTAINING KINASE INHIBITORS
#476Maintenance of platelet inhibition during antiplatelet therapy
#477Benzoxepin PI3K inhibitor compounds and methods of use
#478CONTROLLED DOSING OF CLOPIDOGREL WITH GASTRIC ACID INHIBITION THERAPIES
#479Parasiticidal dihydroisoxazole compounds
#480ANTIVIRAL COMPOUNDS
#481N-substituted hetero-bicyclic furanone derivatives for combating animal
#482Biaryl acetamide compounds and methods of use thereof
#483Maintenance of platelet inhibition during antiplatelet therapy
#484Combination of kinase inhibitors and uses thereof
#485Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
#486Preparation and use of bicyclic himbacine derivatives as PAR-1 receptor antagonists
#487PHASED DOSING OF CLOPIDOGREL
#488Compounds and methods for the treatment of vascular disease
#489Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
#490Methods and compositions for treating nephrogenic diabetes insipidus
#491Benzopyran and benzoxepin PI3K inhibitor compounds and methods of use
#492Method For Treatment Of Macular Degeneration By Modulating P2Y12 or P2X7 Receptors
#493METHODS FOR TREATING CARDIOVASCULAR DISORDER
#494USE OF ALFIMEPRASE IN THE TREATMENT OF THROMBOSIS
#495Inhibitors of HIV replication
#496Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
#497METHODS, APPARATUS, AND COMPOUNDS FOR THE TREATMENT OF CENTRAL RETINAL VEIN OCCLUSION AND OTHER CONDITIONS
#498Thieno [2, 3-B] pyridine derivatives as viral replication inhibitors
#499NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT
#500METHOD OF DETERMINING PRIOR HISTORY OF ISCHEMIC STROKE FOR CURRENT RISK EVALUATION AND THERAPY GUIDANCE
#501TREATMENT OF POTENTIAL PLATELET AGGREGATION WITH LIPOSOMALLY FORMULATED GLUTATHIONE AND CLOPIDOGREL
#502Octahydrothienoquinoline derivative, pharmaceutical composition comprising derivative, and use of these
#503Methods for lowering blood glucose
#504Stable pharmaceutical composition of clopidogrel free base for oral and parenteral delivery
#505METHODS AND COMPOSITIONS FOR THE ASSESSMENT OF DRUG RESPONSE
#506Substituted 6-aza-isoindolin-1-one derivatives
#507Methods for determining patient response to anti-platelet aggregation therapy
#508Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
#509BENZODIOXEPINE AND BENZODIOXINE COMPOUNDS THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES
#510SPHERICAL PARTICLES OF CLOPIDOGREL BISULFATE, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, AND PREPARATION METHOD THEREOF
#511Heteroquinoline-3-carboxamides as KCNQ2/3 modulators
#512Benzoxepin PI3K inhibitor compounds and methods of use
#513Methods of treating autophagy-associated disorders and related pharmaceutical compositions, diagnostics, screening techniques and kits
#514Inhibitors of viral replication, their process of preparation and their therapeutical uses
#515METHOD AND IMPROVED PHARMACEUTICAL COMPOSITION FOR IMPROVING THE ABSORPTION OF AN ESTER PRODRUG
#516Parasiticidal dihydroisoxazole compounds
#517Methods of treating, reducing the incidence of, and/or preventing ischemic events
#518NOVEL ANTIBACTERIAL COMBINATION THERAPY
#5196-arylamino pyridone carboxamide as MEK inhibitors
#520Methods of treating muscular dystrophy
#52117α-hydroxylase/C-lyase inhibitors
#522MOLECULAR SIGNATURE OF CUTANEOUS PIGMENTARY SPOTS, ASSOCIATED WITH THE ORGANIZATION OF THE EXTRACELLULAR MATRIX
#523VON WILLEBRAND FACTOR SPECIFIC BINDERS AND METHODS OF USE THEREFOR
#524Anti-Thrombotic Compounds
#525Therapeutic pyrazolyl thienopyridines
#526Anti-thrombotic compounds
#527Methods for the treatment or prophylaxis of thrombosis or embolism
#528Isoxazole beta-lactamase inhibitors
#529Anti-Thrombotic Compounds
#530Anti-Thrombotic Compounds
#531Compounds for the treatment of -associated disease
#532Soft Elastic Capsules Containing Tablets and Liquid or Semisolid Fills and Methods for Their Manufacture
#533Modulation of factor 11 expression
#534Compounds, compositions and methods useful for cholesterol mobilization
#535Prasugrel containing quickly released stable oral pharmaceutical compositions
#536MAGNETIC NANODRUG FOR TREATING THROMBOSIS
#537METHOD OF PRODUCING A SOLID PREPARATION
#538Benzodioxane inhibitors of leukotriene production for combination therapy
#539Modulators of cystic fibrosis transmembrane conductance regulator
#540IRAK inhibitors and uses thereof
#541Treatment of diabetic patients with a drug eluting stent and adjunctive therapy
#542Parasiticidal dihydroisoxazole compounds
#543PHARMACEUTICAL COMPOSITION COMPRISING ANTIPLATELET AGENTS AND AN ERYTHROPOIESIS STIMULATING AGENT
#544Methods of treating, reducing the incidence of, and/or preventing ischemic events
#545Substituted N- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin C
#546METHODS FOR INHIBITION OF CELL PROLIFERATION, SYNERGISTIC TRANSCRIPTION MODULES AND USES THEREOF
#547Parenteral dextrose formulation of clopidogrel
#548Methods of treating cancer with a thieno[3,2-C]pyridine
#549Analogues of cilostazol
#550Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections
#551Benzopyran and benzoxepin PI3K inhibitor compounds and methods of use
#552METHODS AND COMPOSITIONS FOR TREATING, REVERSING, INHIBITING OR PREVENTING RESISTANCE TO ANTIPLATELET THERAPY
#553Method for treating thrombotic disorders using quercetin-containing compositions
#554COMPOUNDS FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE-ASSOCIATED DISEASE
#555Cellulosic gel material as a pharmaceutical excipient
#5565-HT RECEPTOR MODULATORS
#557Pharmaceutical composition for improving dissolution rate of prasugrel and its preparation method
#558Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
#559Benzoxepin PI3K inhibitor compounds and methods of use
#560Preparation Method Of The Solid Formulation Of Clopidogrel Bisulfate
#561COMBINATION OF DROLOXIFENE AND CLOPIDOGREL
#562Process of forming crystals for use in a personal care composition
#563Solid forms of methyl (7aS,2′S)-2-(2-chlorophenyl)-2-(2,4,5,6,7,7a-hexahydrothieno[3,2-c]-5-pyridin-2-one)acetate
#564ANTI-THROMBOTIC COMPOUNDS
#565Compounds that enhance Atoh1 expression
#566Method for treatment of macular degeneration by modulating P2Y12 or P2X7 receptors
#567GENETIC POLYMORPHISMS ASSOCIATED WITH VENOUS THROMBOSIS, METHODS OF DETECTION AND USES THEREOF
#568Bicyclic thiazoles as allosteric modulators of mGluR5 receptors
#569Thienopyridine NOX2 inhibitors
#570Bicyclic thiazoles as allosteric modulators of mGluR5 receptors
#571USE OF IRBESARTAN FOR THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION OF HOSPITALIZATION FOR HEART FAILURE
#572Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopidogrel therapy
#573MST1 kinase inhibitors and methods of their use
#574Lactam-containing compounds and derivatives thereof as factor XA inhibitors
#575Medicaments for inhibiting thrombus formation
#576Prasugrel in non-crystalline form and pharmaceutical composition thereof
#577Crystal forms of kinase inhibitors
#578THROMBIN RECEPTOR ANTAGONIST AND CLOPIDOGREL FIXED DOSE TABLET
#579MAINTENANCE OF PLATELET INHIBITION DURING ANTIPLATELET THERAPY
#580Inhibitors of HIV replication
#581Compounds, compositions and methods useful for cholesterol mobilisation
#582Assessment of cardiac health and thrombotic risk in a patient
#583Therapeutic approaches for treating neuroinflammatory conditions
#584THERAPEUTIC AGENT FOR MOTOR DISORDERS
#585TGF-Beta Stimulating Agent Compositions and Combinations
#586Crystals of prasugrel hydrobromate
#587METNASE AND INTNASE INHIBITORS AND THEIR USE IN TREATING CANCER
#588METHOD FOR PRODUCING A SOLID PREPARATION
#589METHOD AND COMPOSITION USING A DUAL SPECIFICITY PROTEIN TYROSINE PHOSPHATASE AS AN ANTIMALARIAL DRUG TARGET
#590Thieno [2, 3-B] pyridine derivatives as viral replication inhibitors
#591Therapeutic approaches for treating Alzheimer disease and related disorders through a modulation of angiogenesis
#592Methods for the treatment or prophylaxis of thrombosis or embolism
#593Method of treating thrombocytopenia
#594Combination anticoagulant therapy with a compound that acts as a factor Xa inhibitor
#595PREPARATION AND APPLICATION OF NOVEL ANTIBACTERIAL AND ANTICANCER COMPOUNDS AND THEIR DERIVATIVES
#596Thienopyridine derivatives for the treatment and prevention of dengue virus infections
#597BIOMARKERS FOR DIAGNOSIS OF TRANSIENT ISCHEMIC ATTACKS
#598COMPOUNDS FOR THE TREATMENT OF POSTERIOR SEGMENT DISORDERS AND DISEASES
#599NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#600Diamine Derivatives